collaborative care for lung cancer patients - psychological care alone vs. plus antidepressant (Ver 2.0)

collaborative care for lung cancer patients - psychological support alone compared with pharmacotherapy combination (Ver 2.0)

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0002128

Enrollment

Registered

2016-11-01

Start date

2014-06-16

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug, Behavioral : Control group : collaborative care (programmed care alone) Intervention group : collaborative care (programmed care + escltalopram (5~20mg/day, 12weeks))

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: more than 25years =8 in Hospital Anxiety Depression Scale-Depression or = 4 in Distress Thermometer Inpatient or outpatients of Pulmonary department in Chonnam Nationa University Hwasun Hospital Newly diagnosed inperable lung cancer, within 3 months Use Korean language can Understand purpose of the study

Exclusion criteria

Exclusion criteria: Dementia or major cognitive impairment conditions Acute suicidal risk or Acute psychotic symptoms Known psychotic disorders Acute massive hemorrhage within 1weeks Platelet count less than 130,000 QTc prolonged more than 500msec Severe renal function impairment (Creatinin Clearance (CLCR) < 30ml/min) Taking Antidepressant in enrollment period Untreated or remnant another primary cancer than lung cancer

Design outcomes

Primary

Measure	Time frame
Hospital Anxiety Depression Scale;Distress thermometer	—

Secondary

Measure	Time frame
Disease status / Survival day;Udvalg for Kliniske Undersogelser side effect rating scale (UKU) adverse event;Eastern Cooperative Oncology Group -performance scale;Mini international neuropsychiatric interview-Dignosis of major depressive disorder;Modified Medical Research Council Dyspnea Scale;Confusion Assessment Method;Research Diagnostic Criteria for Insomnia Disorders;Adult Lifestyles and Function Interview -Mini Mental Status Exam (MMSE);European Organisation for Research and Treatment of Cancer Quality of life Questionnaire Quality of life Qustionnaire C30;Beck Hopelessness scale;Restless legs syndrome screening questionnaire;Montgomery Asberg Depression Rating Scale;BPRS suicidality scale	—

Measure

Time frame

Disease status / Survival day;Udvalg for Kliniske Undersogelser side effect rating scale (UKU) adverse event;Eastern Cooperative Oncology Group -performance scale;Mini international neuropsychiatric interview-Dignosis of major depressive disorder;Modified Medical Research Council Dyspnea Scale;Confusion Assessment Method;Research Diagnostic Criteria for Insomnia Disorders;Adult Lifestyles and Function Interview -Mini Mental Status Exam (MMSE);European Organisation for Research and Treatment of Cancer Quality of life Questionnaire Quality of life Qustionnaire C30;Beck Hopelessness scale;Restless legs syndrome screening questionnaire;Montgomery Asberg Depression Rating Scale;BPRS suicidality scale

—

Countries

Korea, Republic of

Contacts

Public ContactSeon-Young Kim

Chonnam National University

tocali@hanmail.net+82-61-379-7763

Outcome results